Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

metlife inc. - MET

MET

Close Chg Chg %
83.04 -3.84 -4.62%

Closed Market

79.20

-3.84 (4.62%)

Volume: 6.41M

Last Updated:

Mar 28, 2025, 3:59 PM EDT

Trade Now

Company Overview: metlife inc. - MET

MET Key Data

Open

$82.92

 Day Range

78.46 - 82.94

52 Week Range

67.31 - 89.03

 Market Cap

$56.58B

Shares Outstanding

681.23M

 Public Float

566.91M

Beta

1.03

 Rev. Per Employee

N/A

P/E Ratio

14.12

 EPS

$6.01

Yield

259.74%

 Dividend

$0.55

EX-DIVIDEND DATE

Feb 4, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

3.51M

  

MET Performance

1 Week
 
 -3.80%
 
1 Month
 
 -8.06%
 
3 Months
 
 -3.67%
 
1 Year
 
 6.91%
 
5 Years
 
 156.66%
 

MET Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 20
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 98.071
Number of Ratings 20 Current Quarters Estimate 2.059
FY Report Date 03 / 2025 Current Year's Estimate 9.374
Last Quarter’s Earnings 2.09 Median PE on CY Estimate N/A
Year Ago Earnings 8.15 Next Fiscal Year Estimate 10.473
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 15 17 17
Mean Estimate 2.06 2.39 9.37 10.47
High Estimates 2.17 2.61 9.80 11.24
Low Estimate 1.97 2.28 9.10 10.10
Coefficient of Variance 3.20 3.40 2.61 3.02

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 12
OVERWEIGHT 1 1 1
HOLD 6 6 5
UNDERWEIGHT 1 1 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Metlife Inc. - MET

Date Name Shares Transaction Value
Mar 14, 2025 Cheryl W. Grisé Director 87,649 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.45 per share 6,876,064.05
Mar 14, 2025 Laura J. Hay Director 2,576 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.45 per share 202,087.20
Mar 14, 2025 Edward Joseph Kelly Director 36,309 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.45 per share 2,848,441.05
Mar 14, 2025 Jeh Charles Johnson Director 5,643 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.45 per share 442,693.35
Mar 14, 2025 William E. Kennard Director 42,199 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.45 per share 3,310,511.55
Mar 14, 2025 Robert Glenn Hubbard Director 97,950 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.45 per share 7,684,177.50
Mar 14, 2025 David Lawrence Herzog Director 25,920 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.45 per share 2,033,424.00
Mar 14, 2025 Carla A. Harris Director 7,357 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.45 per share 577,156.65
Mar 14, 2025 Diana L. McKenzie Director 20,810 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $78.45 per share 1,632,544.50
Mar 6, 2025 Monica Melchionni Curtis EVP & Chief Legal Officer 14,872 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 1,274,530.40
Mar 6, 2025 William Pappas EVP, Global Tech. & Ops. 85,746 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 7,348,432.20
Mar 6, 2025 Marlene B. Debel EVP & Chief Risk Officer 134,135 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 11,495,369.50
Mar 6, 2025 John D. McCallion EVP & Chief Financial Officer 245,129 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 21,007,555.30
Mar 6, 2025 Michel A. Khalaf President & CEO; Director 612,483 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 52,489,793.10
Mar 6, 2025 Tamara L. Schock EVP & Chief Accounting Officer 23,606 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 2,023,034.20
Mar 6, 2025 Ramy Tadros President, U.S. Business 181,368 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 15,543,237.60
Feb 28, 2025 Michel A. Khalaf President & CEO; Director 629,323 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $82.2 per share 51,730,350.60
Feb 28, 2025 Michel A. Khalaf President & CEO; Director 711,550 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Shurawl Sibblies EVP & Chief HR Officer 21,884 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 John D. McCallion EVP & Chief Financial Officer 250,361 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $82.2 per share 20,579,674.20

Metlife Inc. in the News